Portfolio company
Sherlock Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
Mammoth
This company develops CRISPR-based molecular diagnostics and gene-editing therapies for pharmaceutical partners and healthcare providers.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
SeQureDX
This company provides off-target gene-editing analysis and safety diagnostics for biotechnology and pharmaceutical firms developing CRISPR-based therapies.
BillionToOne
This company develops molecular diagnostic tests for prenatal screening and oncology care to help clinicians and patients identify genetic conditions and monitor cancer.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
Mammoth Biosciences
This biotechnology company develops ultracompact CRISPR-based gene editing therapies and diagnostic tools for pharmaceutical partners and healthcare providers.
